Cibus Global LLC
Biotechnology
Healthcare
CBUS
23.59 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.54
52 week high
10.84
high
1.80
52 week low
1.52
low
1.41
growth
-87.62 %
previous Close
1.57
P/E ratio
-0
market cap
69.78 M
div yield
0
usd
Sep 2024
qoq
revenue
1.67 M
98.93 %
net incoming
-179.97 M
-623.26 %
eps
-7.63 %
-569.30 %
eps surprise
-757.30 %
net profit margin
-10795.92 %
-7826.00 %
operating incoming
-200.44 M
-833.05 %
net change in cash
-1.22 M
-122.05 %
cash on hand
28.81 M
-4.05 %
cost of revenue
0.00 %
top top